Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Department of Otorhinolaryngology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
J Int Adv Otol. 2024 Mar 27;20(2):186-188. doi: 10.5152/iao.2024.23122.
Endolymphatic hydrops has been documented as a possible complication of cochlear implantation; however, few studies have addressed its treatment. We describe the first case ever reported of delayed endolymphatic hydrops after a cochlear implant successfully treated with intratympanic gentamicin injection. A detailed discussion of this case with a focus on its management and outcomes will be provided in comparison with literature data. The intratympanic gentamicin injection has been demonstrated to be an effective treatment for symptomatic endolymphatic hydrops after cochlear implantation. We advocate further studies to validate this strategy as a promising alternative to surgical labyrinthectomy.
内淋巴积水已被证实为耳蜗植入的一种可能的并发症;然而,很少有研究涉及到其治疗方法。我们描述了首例经鼓室内注射庆大霉素成功治疗的耳蜗植入后迟发性内淋巴积水病例。我们将详细讨论该病例,并重点讨论其管理和结果,同时与文献数据进行比较。鼓室内注射庆大霉素已被证实为治疗耳蜗植入后症状性内淋巴积水的有效方法。我们主张进一步研究,以验证该策略作为手术迷路切除术的一种有前途的替代方法。